MY LIFE Study - McGill Youth Lifestyle Intervention With Food and Exercise Study
Youth Lifestyle Intervention With Food and Exercise
Sponsors
Source
McGill University
Oversight Info
Has Dmc
No
Brief Summary
Children who are overweight or obese can develop many health complications including
diabetes, high blood pressure, high cholesterol and they break their bones more often than
children who are of healthy body weights. Recent short-term studies in children suggest that
increasing milk intake for 16 weeks begins to improve body composition and also reduces risk
of developing diabetes. However, no study has been long enough to truly test for the benefits
of high milk consumption on these conditions including bone. Both dietary and activity
approaches to reducing obesity in children are suggested by health professionals and when
combined are called lifestyle interventions. Therefore, McGill University has designed a
1-year intervention study focused on lifestyle improvements to reduce obesity in children 6
to 12 years of age. A control group will be monitored for the year, while two other groups
will receive lifestyle interventions with standard recommended (2 servings a day) and high (4
servings a day) intakes of milk. The intervention will include 6 planning sessions to
increase intakes of vegetables, fruits and milks along with more activity and less time
watching television or using computerized games. Children will have muscle and fat measured
using an x-ray device that also measures bone at the beginning, middle and end of the study.
They will also have a small blood sample taken every 3 months to measure blood sugar,
cholesterol and some nutrients. Changes over the study will demonstrate the benefits of
lifestyle and milk interventions.
Detailed Description
Rationale: Childhood obesity is an increasingly major health care problem in Canada. Not only
are approximately 30% of Canadian children overweight/obese, but they are developing
significant sequelae including insulin resistance, hyperinsulinemia, hyperlipidemia,
hypertension, and diabetes mellitus. Additionally obese children have lower bone mass, lower
25(OH)D concentrations and fracture more frequently. Canadian children on average do not meet
the recommended intakes for vegetables and fruit and only half of those < 8 years old meet
the recommended intakes for milk. Obese children are more likely to be inactive and spend
more screen-time during their free time. There is promising childhood evidence that diets
with 3 to 4 servings of milk support healthier body composition (lean mass and height) and
improved insulin sensitivity in the short term and bone mass in the longer term. Family based
interventions are effective in weight reduction in children. To date, a combined assessment
of the benefits of improved intakes of milk plus active lifestyles in obese children on body
composition, bone and blood biochemistry in a family intervention is lacking.
Objectives and Hypotheses:
1. To determine if a 1-year lifestyle intervention with planning sessions designed to
improve diet and activity within the context of the family environment will reduce
adiposity and elevate lean mass while supporting bone mass in obese children compared to
a control group and if augmented intake of milk to 4 daily servings will result in
superior changes. The primary outcome will be change in body mass index (BMI) Z-score
along with waist circumference for assessment of adiposity; selected for ease of use in
larger studies or clinics where body composition assessment is not feasible.
Hypothesis: the lifestyle intervention will yield modest changes to adiposity and lean
mass accompanied by no reductions in bone mass, but that the augmented milk intervention
will yield superior reductions in adiposity and elevations in lean and bone mass and
height growth. It is hypothesized that bone mass will be low and that maintenance of
bone mass in the standard intervention will thereby be judged as inadequate.
2. To explain the hypothesized benefits of these interventions on lean, adipose and bone
masses by measuring indicators of glucose metabolism, satiety and related gut hormones
along with novel biomarkers of skeletal metabolism including osteocalcin, adiponectin
and vitamin D.
Hypothesis: high milk intake will associate with lower glucose, insulin, ghrelin and
1,25(OH)2D accompanied by higher 25(OH)D, osteocalcin, peptide YY and glucagon-like
peptide 1.
3. Test if the intervention with higher milk servings is linked to changes in child eating
behavior and satiety using the Child Eating Behavior Questionnaire to reflect eating in
the child's normal environment.
Hypothesis: children randomized to the high milk intervention group will demonstrate improved
scores on the satiety responsiveness component of the survey.
METHODS - Randomized Controlled Trial Ethics: This study was approved by the McGill
University Institutional Review Board of the Faculty of Medicine in October 2010 and will
also be conducted in compliance with the Tri-Council Policy Statement 2005 and in compliance
with local regulation and laws governing research involving human subjects. Otherwise healthy
obese children (6 to 12 years of age) will be recruited following informed consent. Upon
completion, the control group will be offered the counseling (5 visits) intervention adjusted
for age (i.e. counseling + basic anthropometric measurements only).
Population and Recruitment: Obese children (n=150) from West-Island Montreal and surrounding
off island areas within 50 km of the Macdonald Campus of McGill University. Our approach to
recruitment is to use mailings through Canada Post. This service is excellent and the result
is that for a particular area (predominantly West Island Montreal and off island areas
towards Ottawa) each household receives a brochure on the study inviting them to attend if
they have a child who has a body mass index (BMI) in our range. A graph will be provided to
guide the parents and they will be invited to call us for more information. Obesity will be
defined on the basis of body mass index > 95th percentile for age according to the World
Health Organization. In total 150 children 6 to 12 years of age will be recruited over a
6-month window. Those meeting entrance criteria will be randomized into 3 groups:
1. a control group with information only (counseling after 12 months for 6-8 year olds and
after 6 months for 9-12 year olds);
2. a lifestyle intervention (planning/counseling to improve diet and activity)(6-8 year
olds only);
3. the same lifestyle intervention augmented with a total of 4 servings of milk/milk
products daily (6-12 year olds).
Study Protocol: Participants will be screened for entrance criteria at a visit 2 weeks prior
to beginning the 1-year program. Upon confirmation of meeting inclusion criteria, families
will be telephoned to confirm participation and then 6-8 year olds will be randomized into
the 3 groups stratified for sex and the 9-12 year olds will be randomized into the 2 groups
stratified by sex. They (parents & child) will be asked to complete a 3-day diary of food the
week prior to the baseline visit and at the visit complete questionnaires (activity, eating
behavior, demographics etc.). These will be used as baseline measures for all groups and for
the lifestyle intervention groups to guide interventions regarding food choices and activity
preferences. At the baseline visit, blood sampling, dual energy x-ray absorptiometry (DXA)
and anthropometric measurements will be completed. All groups will receive simple education
at the baseline visit regarding Canada's Food Guide and Canada's Activity Guide and given a
3-day diary to document their food. A registered dietitian will go through the content with
them to explain how to use the guides and food-diary. Then each group will be seen at 3, 6, 9
and 12 months of study to obtain new diaries, and perform anthropometric measurements and
blood biochemistry. Surveys (activity, satiety) will be taken at these visits. Body
composition and bone mass will be measured at baseline, 6 and 12 months. The intervention
groups will have lifestyle counseling visits at the end of months 1 through 5 to enable
individualized family-child counseling (intensive phase) followed by every 3 months
(establishing phase 9 months plus all receive debriefing at 12 months by a study
coordinator). Intervention families will receive a monthly telephone call for any outstanding
issue or to reinforce lifestyle change.
Details of Family-Child counseling at end of months 1 through 5 plus 9 mo (1.5 h visits):
Intervention groups will have planning/counseling sessions for a total of 9 hours based on 5
x 1.5 h visits at the end of months 1 through 5. An additional visit at 9 mo (1.5 h) will be
used to determine if new diet and activity intervention strategies are necessary over time as
the child grows/matures and due to season. Counseling visits at end of months 2, 5 and 9
overlap with regular study visits and will be conducted after study data is collected to
limit leading and bias (same day if need be to limit travel). All intervention planning
visits will be with a registered dietitian. Both intervention groups will be instructed in
detail how to use Canada's Food Guide and Activity Guide (which includes reducing screen
time) and asked to set goals under the family-based behavioral intervention model of Epstein;
while considering the environmental and developmental frameworks to arrive at suitable
planning in the family/near environment plus suitable for the child's developmental age. The
model of Epstein is grounded in the social learning theory in view of the choices, planning
and reinforcement, but adapted for children/families resources and environment with
reinforcement of positive behaviors. Children and families need to change together as a whole
but also in support of the child being able to make decisions while away from home. This has
been applied in an intervention to improve asthma control in children at and away from home.
Canada's food guide servings for Milk and Alternatives (these include for example 250 ml
fluid milk, 250 ml soy beverage, 175 g yogurt, 175 kefir, 50 g cheese) is 2 per day for
children 4 to 8 years of age and servings of vegetables and fruits is 5 per day. The
augmented intervention group will be instructed to consume 4 servings of milk or milk
products daily (these include for example 250 ml fluid milk, 175 g yogurt, 50 g cheese). The
4 servings of milk aligns with the recommended servings for 9 to 14 year old children; the
age at the end of the study or soon thereafter. This intervention approach is both ethical
and forward-looking. It would be unethical to counsel children and parents to not achieve the
recommended 2 servings of milk and alternative products for an 8 year old. Upon completion of
the study the investigators will survey families regarding sustainability of intakes at 4
servings a day - for children turning 9 years old this is the recommendation.
The intervention groups will also have counseling on other food groups to result in a healthy
diet overall. Meal planning at each visit for both interventions will use Canada's Food Guide
and include age appropriate serving sizes, approaches to combining foods to enhance satiety,
how to incorporate snacks and fun foods, cooking methods, hidden energy, and how to
specifically increase vegetables, fruit and milk intakes for the family. The examples of
servings listed previously are only a few. Within each family food preferences and
availability will be used to counsel towards achieving 2 or 4 servings of milk and milk
products a day. Similar family-based dietary interventions have been successfully used in
overweight and obese children 6 years of age and higher. The intervention groups will also
actively plan to increase activity according to the Activity Guide which includes increasing
activity to 90 minutes daily and decrease in non-active time by 90 minutes over 5 months
(hence the visits at end of months 1 through 5). The new My Food Guide on-line at Health
Canada offers a convenient tool for planning of both diet and activity that can be used over
the course of the study in conjunction with the full Health Canada educational tool for
planning the 5-month increase in activity and reduction in screen time. Planning with parents
and children together within the context of their environment, developmental stage and food
and activity preferences is anticipated to improve the program's success. A focus on fun yet
feasible activities will assist both children and parents in adhering to the program. Expert
researchers and health care professionals have designed both of these Health Canada tools. In
fact these tools are used in the Montreal Children's Hospital obesity clinics. The activity
guide has been successfully used in a 4 week family program to enhance activity.
Overall Status
Completed
Start Date
2010-12-01
Completion Date
2014-05-01
Primary Completion Date
2014-05-01
Phase
N/A
Study Type
Interventional
Primary Outcome
Measure |
Time Frame |
Body Composition |
Baseline and following 3, 6, 9 and 12 months of study participation. |
Secondary Outcome
Measure |
Time Frame |
Blood Biochemistry |
Baseline and following 3, 6, 9 and 12 months of study participation. |
Satiety Scores |
Following 12 months of study participation. |
Bone Mass |
Baseline and following 3, 6, 9 and 12 months of study participation. |
Enrollment
132
Conditions
Intervention
Intervention Type
Behavioral
Intervention Name
Description
Subjects in this group will receive family based counseling to maintain the intake of 2 servings of dairy per day and also receive instruction on how to improve their physical activity.
Arm Group Label
2 servings dairy + exercise 6-8 yrs
Other Name
2 servings of dairy and exercise
Intervention Type
Behavioral
Intervention Name
Description
Subjects in this group will receive family based counseling to increase intake of dairy to 4 servings per day and also receive instruction on how to improve their physical activity.
Arm Group Label
4 servings dairy + exercise 6-8 yrs
4 servings dairy + exercise 9-12 yrs
Other Name
4 servings of dairy and exercise
Intervention Type
Behavioral
Intervention Name
Description
The group will receive information during the study about diet and exercise but will not receive the intervention until 6 months into the study protocol.
Arm Group Label
Control 6-8 yrs
Control 9-12 yrs
Eligibility
Criteria
Inclusion Criteria:
- Participants must be between 6 and 12 years of age at onset of the intervention
- Consume < 2 servings of milk and milk products but be receptive to the recommendations
- Have body mass index (BMI) over the 97 percentile for age and sex according to the
World Health Organization. The Canadian Community Health Survey (CCHS)assessment of
obesity used the definition by the International Obesity Task Force. This yields
similar results as when using BMI percentile cut-offs proposed by the World Health
Organization (WHO) for all ages of children. The WHO now has reference data available
to 19 years of age. The BMI values at the 97th percentile are lower compared to the
2000 Centres for Disease Control charts
(http://www.who.int/growthref/who2007_bmi_for_age/en/index.html).
Exclusion Criteria:
1. Known or suspected serious, chronic illness of childhood, such as cancer, Crohn's
disease, nephrotic syndrome, rheumatic conditions, and diabetes, etc., or those with
disturbances in bone, vitamin D or mineral ion metabolism including rickets,
osteomalacia, liver disease, renal disease, immobilization (complete or partial),
current fractures, and disorders of the parathyroid gland.
2. Use in the past 3 months, medications known to affect bone and/or mineral ion
metabolism including all glucocorticoids, phosphate therapy or vitamin D analogues and
any bisphosphonates.
3. Severe anemia precluding blood sampling (previously diagnosed).
4. Established diabetes mellitus (any type). Use of a glucometer and finger lance will
confirm.
5. Hyperlipidemia ascribed to non-dietary causes.
Gender
All
Minimum Age
6 Years
Maximum Age
12 Years
Healthy Volunteers
Accepts Healthy Volunteers
Overall Official
Last Name |
Role |
Affiliation |
Hope A Weiler, PhD, RD |
Principal Investigator |
McGill University |
Celia Rodd, MD |
Principal Investigator |
Montreal Children's Hospital of the MUHC |
Hugues Plourde, RD, PhD |
Principal Investigator |
McGill University |
Location
Facility |
Mary Emily Clinical Nutrition Research Unit of McGill University Sainte Anne-de-Bellevue Quebec H9X 2E3 Canada |
Location Countries
Country
Canada
Verification Date
2015-04-01
Lastchanged Date
N/A
Firstreceived Date
N/A
Responsible Party
Responsible Party Type
Principal Investigator
Investigator Affiliation
McGill University
Investigator Full Name
Hope Weiler
Investigator Title
Associate professor
Keywords
Has Expanded Access
No
Condition Browse
Number Of Arms
5
Arm Group
Arm Group Label
Control 6-8 yrs
Arm Group Type
Active Comparator
Description
The group will receive information during the study about diet and exercise but will not receive the intervention till the end of the study protocol.
Arm Group Label
2 servings dairy + exercise 6-8 yrs
Arm Group Type
Experimental
Description
Subjects in this group will receive family based counseling to maintain the intake of 2 servings of dairy per day and also receive instruction on how to improve their physical activity.
Arm Group Label
4 servings dairy + exercise 6-8 yrs
Arm Group Type
Experimental
Description
Subjects in this group will receive family based counselling to maintain the intake of 4 servings of dairy per day and also receive instruction on how to improve their physical activity.
Arm Group Label
4 servings dairy + exercise 9-12 yrs
Arm Group Type
Experimental
Description
Subjects in this group will receive family based counselling to maintain the standard recommended intake of 4 servings of dairy per day for 9-14 year olds according to the Canada's Food Guide and also receive instruction on how to improve their physical activity.
Arm Group Label
Control 9-12 yrs
Arm Group Type
Active Comparator
Description
The group will receive information during the study about diet and exercise but will not receive the intervention until 6 months into the study protocol.
Firstreceived Results Date
N/A
Acronym
MYLIFE
Firstreceived Results Disposition Date
N/A
Study Design Info
Allocation
Randomized
Intervention Model
Parallel Assignment
Primary Purpose
Treatment
Masking
None (Open Label)
Study First Submitted
February 1, 2011
Study First Submitted Qc
February 3, 2011
Study First Posted
February 4, 2011
Last Update Submitted
April 7, 2015
Last Update Submitted Qc
April 7, 2015
Last Update Posted
April 8, 2015
ClinicalTrials.gov processed this data on December 05, 2019
Conditions
Conditions usually refer to a disease, disorder, syndrome, illness, or injury. In ClinicalTrials.gov,
conditions include any health issue worth studying, such as lifespan, quality of life, health risks, etc.
Interventions
Interventions refer to the drug, vaccine, procedure, device, or other potential treatment being studied.
Interventions can also include less intrusive possibilities such as surveys, education, and interviews.
Study Phase
Most clinical trials are designated as phase 1, 2, 3, or 4, based on the type of questions
that study is seeking to answer:
In Phase 1 (Phase I) clinical trials, researchers test a new drug or treatment in a small group of people (20-80) for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
In Phase 2 (Phase II) clinical trials, the study drug or treatment is given to a larger group of people (100-300) to see if it is effective and to further evaluate its safety.
In Phase 3 (Phase III) clinical trials, the study drug or treatment is given to large groups of people (1,000-3,000) to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
In Phase 4 (Phase IV) clinical trials, post marketing studies delineate additional information including the drug's risks, benefits, and optimal use.
These phases are defined by the Food and Drug Administration in the Code of Federal Regulations.
In Phase 1 (Phase I) clinical trials, researchers test a new drug or treatment in a small group of people (20-80) for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
In Phase 2 (Phase II) clinical trials, the study drug or treatment is given to a larger group of people (100-300) to see if it is effective and to further evaluate its safety.
In Phase 3 (Phase III) clinical trials, the study drug or treatment is given to large groups of people (1,000-3,000) to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
In Phase 4 (Phase IV) clinical trials, post marketing studies delineate additional information including the drug's risks, benefits, and optimal use.
These phases are defined by the Food and Drug Administration in the Code of Federal Regulations.